On the public citation graph
Evaluating the Effect of Dual GIPR/GLP-1R Agonists on Non-Alcoholic Fatty Liver Disease and Metabolic Risk Abnormalities: A Drug-Target Mendelian Randomization Study
0 signed · 42 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2021.18236openalex-extracted
Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization
inferredcites →https://doi.org/10.1002/gepi.22077openalex-extracted
Mendelian randomization with fine‐mapped genetic data: Choosing from large numbers of correlated instrumental variables
inferredcites →https://doi.org/10.1002/hep.25539openalex-extracted
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep.25739openalex-extracted
Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism
inferredcites →https://doi.org/10.1002/hep.28287openalex-extracted
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep.28827openalex-extracted
Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study
inferredcites →https://doi.org/10.1002/hep.32228openalex-extracted
Global burden of NAFLD and chronic liver disease among adolescents and young adults
inferredcites →https://doi.org/10.1007/s00125-021-05564-7openalex-extracted
Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling
inferredcites →https://doi.org/10.1007/s00125-022-05743-0openalex-extracted
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study
inferredcites →https://doi.org/10.1007/s10654-015-0011-zopenalex-extracted
Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors
inferredcites →https://doi.org/10.1007/s40265-022-01746-8openalex-extracted
Tirzepatide: First Approval
inferredcites →https://doi.org/10.1016/j.ajhg.2022.04.001openalex-extracted
Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches
inferredcites →https://doi.org/10.1016/j.cmet.2022.05.003openalex-extracted
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
inferredcites →https://doi.org/10.1016/j.jhep.2017.10.015openalex-extracted
Pharmacotherapy for NASH: Current and emerging
inferredcites →https://doi.org/10.1016/j.jhep.2018.05.036openalex-extracted
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
inferredcites →https://doi.org/10.1016/j.jhep.2019.06.031openalex-extracted
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.jhep.2020.03.039openalex-extracted
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
inferredcites →https://doi.org/10.1016/j.jhep.2023.04.036openalex-extracted
Changing epidemiology, global trends and implications for outcomes of NAFLD
inferredcites →https://doi.org/10.1016/j.xcrm.2021.100437openalex-extracted
Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/s0140-6736(19)32517-6openalex-extracted
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
inferredcites →https://doi.org/10.1016/s2468-1253(22)00165-0openalex-extracted
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1038/79216openalex-extracted
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
inferredcites →https://doi.org/10.1038/ng.3785openalex-extracted
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
inferredcites →https://doi.org/10.1038/nrgastro.2013.41openalex-extracted
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
inferredcites →https://doi.org/10.1038/s41588-018-0099-7openalex-extracted
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
inferredcites →https://doi.org/10.1038/s41588-018-0241-6openalex-extracted
Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps
inferredcites →https://doi.org/10.1038/s41588-021-00913-zopenalex-extracted
Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
inferredcites →https://doi.org/10.1038/s41591-021-01425-3openalex-extracted
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
inferredcites →https://doi.org/10.1074/jbc.m609088200openalex-extracted
Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes
inferredcites →https://doi.org/10.1093/ije/dyv080openalex-extracted
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
inferredcites →https://doi.org/10.1097/ede.0000000000000559openalex-extracted
Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants
inferredcites →https://doi.org/10.1097/hep.0000000000000004openalex-extracted
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
inferredcites →https://doi.org/10.1097/hep.0000000000000412openalex-extracted
A call for unity: The path towards a more precise and patient-centric nomenclature for NAFLD
inferredcites →https://doi.org/10.1101/2020.08.10.244293openalex-extracted
The MRC IEU OpenGWAS data infrastructure
inferredcites →https://doi.org/10.1101/787903openalex-extracted
The GTEx Consortium atlas of genetic regulatory effects across human tissues
inferredcites →https://doi.org/10.1148/radiol.14140754openalex-extracted
Accuracy of MR Imaging–estimated Proton Density Fat Fraction for Classification of Dichotomized Histologic Steatosis Grades in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1161/jaha.120.020331openalex-extracted
Genetic Evidence for Repurposing of GLP1R (Glucagon‐Like Peptide‐1 Receptor) Agonists to Prevent Heart Failure
inferredcites →https://doi.org/10.1194/jlr.m006841openalex-extracted
GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene
inferredcites →https://doi.org/10.12688/wellcomeopenres.15555.1openalex-extracted
Guidelines for performing Mendelian randomization investigations
inferredcites →https://doi.org/10.1371/journal.pgen.1004383openalex-extracted
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
inferredcites →https://doi.org/10.2337/db09-0143openalex-extracted
Coexpression of the Type 2 Diabetes Susceptibility Gene Variants KCNJ11 E23K and ABCC8 S1369A Alter the ATP and Sulfonylurea Sensitivities of the ATP-Sensitive K+ Channel
inferredcites →https://doi.org/10.2337/dc22-0323openalex-extracted
SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.